drugset / Trial / NCT01906788

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

NCT01906788

RandomizedSingle-groupOpen-label

Summary

The investigators' Hypothesis is that "The correct timing of gametocytocidal drug in combination with an effective Artemisinin Combination Therapy can limit the infectiousness of malaria-infected individuals to less than one week after initiation of treatment"

Timeline

Start
2013-05
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Primaquine Small molecule 0.75 mg/kg
Comparator Artemether-lumefantrine Unknown Oral

Indications